Previous Close | 9.37 |
Open | 9.34 |
Bid | 9.70 x 1400 |
Ask | 9.74 x 900 |
Day's Range | 9.30 - 10.57 |
52 Week Range | 3.14 - 33.79 |
Volume | 19,984,455 |
Avg. Volume | 10,641,003 |
Market Cap | 1.636B |
Beta (5Y Monthly) | 1.08 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
This coronavirus vaccine drugmaker has already made many of its early investors rich, but its valuation is still dirt cheap.
Analysts have very different takes on the early-stage results for the company's COVID-19 vaccine candidate.